Skip to main content

MedBrevia

Loading…

Skip to main content

Built by clinicians, backed by citations, privacy-first. No ads.

Literature Search

Search millions of biomedical articles with AI filters.

Clinical Trials Explorer

Search ClinicalTrials.gov studies by condition, intervention, eligibility, and results.

Chat

Ask questions and get citable answers from our literature corpus.

Grand Rounds Dashboard

Synthesis of the latest research in your field.

Saved Library

Bookmark, tag, and annotate papers.

Medical Calculators

CHA2DS2-VASc, MELD-Na, ASCVD, Wells, and more.

Back to Grand Rounds

Grand Rounds

Cardiology issue navigator

Diagnosis and treatment of heart disorders and cardiovascular diseases.

Select a year

Newest Grand Rounds

Jul 4, 2026

Grand Rounds: Recent cardiovascular evidence briefs

Open latest issue

Recent issues

Jun 27, 2026

Five recent cardiovascular studies with direct clinical implications: device therapy, ATTR-CM therapy, perioperative and post-PCI risk prediction, and ARB versus ACEI outcomes

Jun 20, 2026

Selected recent evidence affecting cardiovascular therapeutics, trials, and digital tools

Jun 13, 2026

Grand Rounds: Practical evidence briefs for cardiology

Browse Grand Rounds

Weekly issues

CardiologyLatest first

Publication year

2026

Newest first

Feb 14, 2026

Long-term AF ablation, HF telemonitoring, and imaging-driven risk across the cardio–kidney–metabolic spectrum

Pulsed field ablation versus conventional thermal ablation for paroxysmal atrial fibrillation: 4-year outcomes in the ADVENT-LTO study.

Jan 24, 2026

Prognosis across myocardial injury types, refined AR thresholds, blood pressure risks, and evolving tools from wearables to tricuspid and lipid interventions

Cardiovascular Risk Across Myocardial Injury and Infarction Categories Using the Universal Definition: An Individual Patient-Level Data Meta-Analysis.

Jan 17, 2026

Revascularization, HFpEF diagnostics, and arrhythmia management: concise updates for cardiology practice

Fractional flow reserve-guided percutaneous coronary intervention versus medical therapy for stable coronary artery disease: long-term results of the FAME 2 trial.

Jan 10, 2026

Targeted secondary prevention, procedural strategy, and AI-driven risk tools in contemporary cardiology

β-Blockers After Myocardial Infarction in Patients With Preserved Ejection Fraction: A Meta-Analysis.

Publication year

2025

Newest first

Dec 27, 2025

Shorter DAPT, GLP-1 Benefits, CCB Safety Signal, and Emerging Genomic and Biomarker Tools

Three vs 12-month DAPT after implantation of biodegradable-polymer sirolimus-eluting coronary stent: a randomised clinical trial.

Dec 20, 2025

Practice-shaping evidence in coronary intervention, heart failure, biomarkers, and prevention

Physiology vs angiography-guided percutaneous coronary intervention in transcatheter aortic valve implantation: the FAITAVI trial.

Dec 13, 2025

Refining cardiovascular therapy: who to treat, how aggressively, and with which modality

Blood pressure lowering in isolated diastolic hypertension and cardiovascular risk: an individual patient data meta-analysis.

Dec 6, 2025

Targeted therapeutics reshaping contemporary cardiovascular practice

Aficamten in Obstructive Hypertrophic Cardiomyopathy: A Multidomain, Patient-Level Analysis of the MAPLE-HCM Trial.

Nov 29, 2025

Evolving Risk and Therapy Across Coronary Disease, Heart Failure, and Cardiac Amyloidosis

Frailty and long-term outcomes in younger patients with acute myocardial infarction.

Nov 22, 2025

Early risk signals and procedural optimization in contemporary cardiovascular practice

Blood Pressure in Adolescence and Atherosclerosis in Middle Age.

Page 3 of 4

Previous 1 2 3 4 Next

MedBrevia

Accelerating clinical insights with clinical research to support evidence-based medicine.

Product

Search
Grand Rounds
Calculators

Account

Dashboard
Signup

Legal

Privacy Policy
Terms of Service
Cookie Preferences
Disclaimer

© 2026 MedBrevia. All rights reserved.

Twitter LinkedIn Blog RSS